Jyong Biotech Ltd. (MENS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$1.89

From 52W high−96.83%

Volume44819.00

Market cap$146.73M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$1.89

From 52W high

−96.83%

Volume

44819.00

Market cap

$146.73M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−62.5x

P/E (TTM)

—

RSI (14)

40.0

MomentumView details →

1D Return

+4.89%

YTD Return

−52.15%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−62.5x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−5.9x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

18.76%

ROA (TTM)

−22.49%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

+100.00%

Revenue CAGR 3Y

—

EPS CAGR 3Y

−61.21%

EBITDA YoY

—

MomentumView details →

1D Return

+4.89%

YTD Return

−52.15%

1Y Return

−96.80%

RSI (14)

40.0

vs 50D SMA

−10.48%

vs 200D SMA

−15.46%

Capital & dividendView details →

Debt/Equity

−0.74x

Current Ratio

0.45x

Quick Ratio

0.45x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−4.67M

Op. CF (TTM)

0.00

Latest newsMore news →

Jyong Biotech announced plans to establish a manufacturing facility and U.S. operations center in Texas to support its U.S. operations and potential future commercialization of its drug candidates, if approved.5d ago

Similar companies

Pyxis Oncology, Inc.PYXS Coherus Oncology, Inc.CHRS Codexis, Inc.CDXS Compass Therapeutics, Inc.CMPX NovaBridge BiosciencesNBP Veraxa Biotech Holding AGVRXA Find similar companies →

Latest newsMore news →

Jyong Biotech announced plans to establish a manufacturing facility and U.S. operations center in Texas to support its U.S. operations and potential future commercialization of its drug candidates, if approved.5d ago